| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |